Literature DB >> 12480088

Filamin C accumulation is a strong but nonspecific immunohistochemical marker of core formation in muscle.

C G Bönnemann1, T G Thompson, P F M van der Ven, H H Goebel, I Warlo, B Vollmers, J Reimann, J Herms, M Gautel, F Takada, A H Beggs, D O Fürst, L M Kunkel, F Hanefeld, R Schröder.   

Abstract

Filamin C is the muscle isoform of a group of large actin-crosslinking proteins. On the one hand, filamin C is associated with the Z-disk of the myofibrillar apparatus and binds to myotilin; on the other hand, it interacts with the sarcoglycan complex at the sarcolemma. Filamin C may be involved in reorganizing the cytoskeleton in response to signalling events and in muscle it may, in addition, fulfill structural functions at the Z-disk. An examination of biopsies from patients with multi-minicore myopathy, central core myopathy and neurogenic target fibers with core-like target formations (TF) revealed strong reactivity of all the cores and target formations with two different anti-filamin C antibodies. In all three conditions, the immunoreactivity in the cores for filamin C was considerably stronger than that for desmin. Only for alphaB-crystallin were comparable levels of immunoreactivity detected. There was no difference in intensity for filamin C between the three pathological conditions. Thus, filamin C along with alphaB-crystallin is a strong and robust, but nonspecific marker of core formation. The reason why filamin C accumulates in cores is unclear at present, but we postulate that it may be critically involved in the chain of events eventually leading to myofibrillar degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480088     DOI: 10.1016/s0022-510x(02)00341-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.

Authors:  I Dalkilic; J Schienda; T G Thompson; L M Kunkel
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Myofibrillar Z-discs Are a Protein Phosphorylation Hot Spot with Protein Kinase C (PKCα) Modulating Protein Dynamics.

Authors:  Lena Reimann; Heike Wiese; Yvonne Leber; Anja N Schwäble; Anna L Fricke; Anne Rohland; Bettina Knapp; Christian D Peikert; Friedel Drepper; Peter F M van der Ven; Gerald Radziwill; Dieter O Fürst; Bettina Warscheid
Journal:  Mol Cell Proteomics       Date:  2016-12-27       Impact factor: 5.911

3.  Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2.

Authors:  Pankaj B Agrawal; Rebecca S Greenleaf; Kinga K Tomczak; Vilma-Lotta Lehtokari; Carina Wallgren-Pettersson; William Wallefeld; Nigel G Laing; Basil T Darras; Sutherland K Maciver; Philip R Dormitzer; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2006-11-14       Impact factor: 11.025

4.  Identification of CAP as a costameric protein that interacts with filamin C.

Authors:  Mei Zhang; Jun Liu; Alan Cheng; Stephanie M Deyoung; Alan R Saltiel
Journal:  Mol Biol Cell       Date:  2007-09-26       Impact factor: 4.138

5.  Identification of filamin C as a new physiological substrate of PKBalpha using KESTREL.

Authors:  James T Murray; David G Campbell; Mark Peggie; Alfonso Mora; Mora Alfonso; Philip Cohen
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

Review 6.  Pathological defects in congenital myopathies.

Authors:  Caroline A Sewry
Journal:  J Muscle Res Cell Motil       Date:  2008-12-30       Impact factor: 2.698

7.  HSPB7 interacts with dimerized FLNC and its absence results in progressive myopathy in skeletal muscles.

Authors:  Liang-Yi Juo; Wern-Chir Liao; Yen-Ling Shih; Bih-Ying Yang; An-Bang Liu; Yu-Ting Yan
Journal:  J Cell Sci       Date:  2016-02-29       Impact factor: 5.285

8.  Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Authors:  Alex Kentsis; Andrew Shulman; Saima Ahmed; Eileen Brennan; Michael C Monuteaux; Young-Ho Lee; Susan Lipsett; Joao A Paulo; Fatma Dedeoglu; Robert Fuhlbrigge; Richard Bachur; Gary Bradwin; Moshe Arditi; Robert P Sundel; Jane W Newburger; Hanno Steen; Susan Kim
Journal:  EMBO Mol Med       Date:  2012-12-20       Impact factor: 12.137

Review 9.  Central core disease.

Authors:  Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2007-05-15       Impact factor: 4.123

Review 10.  Multi-minicore Disease.

Authors:  Heinz Jungbluth
Journal:  Orphanet J Rare Dis       Date:  2007-07-13       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.